The importance of the Phase III JAVELIN LUNG 100 trial in non-small-cell lung cancer
Does MRI has the ability to transform how prostate cancer is seen and managed?
Should imaging-guided prostate cancer biopsy be used for both first and repeat biopsies?
The impact of p53 mutation on survival in EGFR-mutated NSCLC patients
The changing landscape of NSCLC diagnosis, monitoring and treatment